Rockwell Medical, Inc. / Fundamentals
Income statement
- Net revenue
€75.47M - Cost of goods sold
€62.25M - Gross profit
€13.23M - SG&A expenses
€14.33M - R&D expenses
€858.00 - EBITDA
€489.92K - D&A
€1.41M - EBIT
-€1.11M - Interest expenses
€506.22K - EBT
-€1.80M - Tax expenses
€0.00 - Net income
-€1.80M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€523.38K - Changes in working capital
€3.58M - Operating cash flow
€3.00M - Capex
€643.50K - Other investing cash flow
-€10.30K - Net investing cash flow
-€5.62M - Total cash dividends paid
€0.00 - Issuance of common stock
€6.36M - Debt repayment
-€771.34K - Other financing cash flow
-€2.32M - Net financing cash flow
€3.15M - Foreign exchange effects
-€1.72K - Net change in cash
€531.10K - Cash at end of period
€10.71M - Free cash flow
€3.64M
Balance sheet
- Cash and cash equivalents
€10.71M - Cash and short-term investments
€15.81M - Total receivables
€6.94M - Inventory
€3.57M - Other current assets
€809.09K - Total current assets
€27.12M - Property, plant & equipment
€8.24M - Goodwill
€790.22K - Intangible assets
€8.52M - Long-term investments
€0.00 - Other non-current assets
€481.34K - Total non-current assets
€18.03M - Total assets
€45.15M - Accounts payable
€1.29M - Short-term debt
€2.35M - Other current liabilities
€5.66M - Total current liabilities
€9.39M - Long-term debt
€9.67M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€9.67M - Total liabilities
€19.06M - Common stock
€2.57K - Retained earnings
-€343.79M - Other equity
€48.91K - Total equity
€26.09M - Total liabilities and shareholders' equity
€45.15M
Company information
- Market capitalization
€23.09M - Employees
244 - Enterprise Value
€32.73M
Company ratios
- Gross margin
-
17.5% Much better than peer group: -4,894.0% - EBITDA margin
-
0.6% Much worse than peer group: 802,689.5% - EBIT margin
-
-1.5% Much worse than peer group: 755,435.6% - EBT margin
-
-2.4% Much worse than peer group: 802,800.2% - Net margin
-
-2.4% Much worse than peer group: 727,332.5% - ROE
-
-6.9% Much worse than peer group: 27.3% - ROA
-
-4.0% Much better than peer group: -16,583.8% - Asset turnover
-
167.2% Much worse than peer group: 4,674.2% - FCF margin
-
3.1% Much worse than peer group: 564,416.5% - FCF yield
10.2% - Efficiency ratio
99.4% - Net sales per employee
-
€309.32K - Net income per employee
-
-€7.38K